Clinical Trial Update: Pharmacokinetics, Pharmacodynamics and Safety of Epeleuton in Patients With Sickle Cell Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating the pharmacokinetics, pharmacodynamics, and safety of Epeleuton in patients with Sickle Cell Disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• Epeleuton (Epeleuton)

Snippet

Sponsor: Afimmune | Conditions: Sickle Cell Disease | Phase 2 | Status: ACTIVE_NOT_RECRUITING